{"pmid":32467125,"title":"Morphology of COVID-19-affected cells in peripheral blood film.","text":["Morphology of COVID-19-affected cells in peripheral blood film.","BMJ Case Rep","Singh, Aminder","Sood, Neena","Narang, Vikram","Goyal, Abhishek","32467125"],"journal":"BMJ Case Rep","authors":["Singh, Aminder","Sood, Neena","Narang, Vikram","Goyal, Abhishek"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467125","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/bcr-2020-236117","keywords":["pathology","pneumonia (respiratory medicine)","travel medicine"],"topics":["Case Report"],"weight":1,"_version_":1668167110051758080,"score":9.490897,"similar":[{"pmid":32279346,"title":"Morphological anomalies of circulating blood cells in COVID-19.","text":["Morphological anomalies of circulating blood cells in COVID-19.","Am J Hematol","Zini, Gina","Bellesi, Silvia","Ramundo, Francesco","d'Onofrio, Giuseppe","32279346"],"journal":"Am J Hematol","authors":["Zini, Gina","Bellesi, Silvia","Ramundo, Francesco","d'Onofrio, Giuseppe"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279346","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/ajh.25824","topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666138491594997760,"score":43.369766},{"pmid":32404376,"title":"Hypogeusia as the initial presenting symptom of COVID-19.","text":["Hypogeusia as the initial presenting symptom of COVID-19.","COVID-19 is the disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first arose in Wuhan, China, in December 2019 and has since been declared a pandemic. The clinical sequelae vary from mild, self-limiting upper respiratory infection symptoms to severe respiratory distress, acute cardiopulmonary arrest and death. Otolaryngologists around the globe have reported a significant number of mild or otherwise asymptomatic patients with COVID-19 presenting with olfactory dysfunction. We present a case of COVID-19 resulting in intensive care unit (ICU) admission, presenting with the initial symptom of disrupted taste and flavour perception prior to respiratory involvement. After 4 days in the ICU and 6 days on the general medicine floor, our patient regained a majority of her sense of smell and was discharged with only lingering dysgeusia. In this paper, we review existing literature and the clinical course of SARS-CoV-2 in relation to the reported symptoms of hyposmia, hypogeusia and dysgeusia.","BMJ Case Rep","Melley, Lauren E","Bress, Eli","Polan, Erik","32404376"],"abstract":["COVID-19 is the disease caused by the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which first arose in Wuhan, China, in December 2019 and has since been declared a pandemic. The clinical sequelae vary from mild, self-limiting upper respiratory infection symptoms to severe respiratory distress, acute cardiopulmonary arrest and death. Otolaryngologists around the globe have reported a significant number of mild or otherwise asymptomatic patients with COVID-19 presenting with olfactory dysfunction. We present a case of COVID-19 resulting in intensive care unit (ICU) admission, presenting with the initial symptom of disrupted taste and flavour perception prior to respiratory involvement. After 4 days in the ICU and 6 days on the general medicine floor, our patient regained a majority of her sense of smell and was discharged with only lingering dysgeusia. In this paper, we review existing literature and the clinical course of SARS-CoV-2 in relation to the reported symptoms of hyposmia, hypogeusia and dysgeusia."],"journal":"BMJ Case Rep","authors":["Melley, Lauren E","Bress, Eli","Polan, Erik"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32404376","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1136/bcr-2020-236080","keywords":["adult intensive care","ear, nose and throat/otolaryngology","infectious diseases","mouth","pneumonia (respiratory medicine)"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1666950579834847232,"score":40.17404},{"pmid":32467124,"title":"80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.","text":["80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.","COVID-19 is a novel viral infection caused by severe acute respiratory syndrome-coronavirus-2 virus, first identified in Wuhan, China in December 2019. COVID-19 has spread rapidly and is now considered a global pandemic. We present a case of a patient with minimal respiratory symptoms but prominent bilateral groundglass opacities in a 'crazy paving' pattern on chest CT imaging and a negative initial infectious workup. However, given persistent dyspnoea and labs suggestive of COVID-19 infection, the patient remained hospitalised for further monitoring. Forty-eight hours after initial testing, the PCR test was repeated and returned positive for COVID-19. This case illustrates the importance of clinical vigilance to retest patients for COVID-19, particularly in the absence of another compelling aetiology. As COVID-19 testing improves to rapidly generate results, selective retesting of patients may uncover additional COVID-19 cases and strengthen measures to minimise the spread of COVID-19.","BMJ Case Rep","Samec, Matthew J","Khawaja, Ali","Patel, Ashokakumar M","Dugani, Sagar B","32467124"],"abstract":["COVID-19 is a novel viral infection caused by severe acute respiratory syndrome-coronavirus-2 virus, first identified in Wuhan, China in December 2019. COVID-19 has spread rapidly and is now considered a global pandemic. We present a case of a patient with minimal respiratory symptoms but prominent bilateral groundglass opacities in a 'crazy paving' pattern on chest CT imaging and a negative initial infectious workup. However, given persistent dyspnoea and labs suggestive of COVID-19 infection, the patient remained hospitalised for further monitoring. Forty-eight hours after initial testing, the PCR test was repeated and returned positive for COVID-19. This case illustrates the importance of clinical vigilance to retest patients for COVID-19, particularly in the absence of another compelling aetiology. As COVID-19 testing improves to rapidly generate results, selective retesting of patients may uncover additional COVID-19 cases and strengthen measures to minimise the spread of COVID-19."],"journal":"BMJ Case Rep","authors":["Samec, Matthew J","Khawaja, Ali","Patel, Ashokakumar M","Dugani, Sagar B"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32467124","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1136/bcr-2020-236069","keywords":["pneumonia (respiratory medicine)","respiratory system"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report"],"weight":1,"_version_":1668167109948997632,"score":40.17404}]}